| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.27e-08 | 188 | 12 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.07e-04 | 891 | 12 | 5 | GO:0005198 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.67e-04 | 187 | 12 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 3.21e-04 | 596 | 12 | 4 | GO:0140678 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 4.25e-04 | 257 | 12 | 3 | GO:0061134 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 8.50e-04 | 73 | 12 | 2 | GO:0001786 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 1.95e-03 | 435 | 12 | 3 | GO:0004857 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 2.35e-03 | 122 | 12 | 2 | GO:0072341 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 5.03e-03 | 180 | 12 | 2 | GO:0004866 | |
| GeneOntologyMolecularFunction | heparin binding | 5.70e-03 | 192 | 12 | 2 | GO:0008201 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 6.23e-03 | 201 | 12 | 2 | GO:0061135 | |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 3.24e-05 | 15 | 12 | 2 | GO:0043652 | |
| GeneOntologyBiologicalProcess | negative regulation of angiogenesis | 1.25e-04 | 175 | 12 | 3 | GO:0016525 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel morphogenesis | 1.31e-04 | 178 | 12 | 3 | GO:2000181 | |
| GeneOntologyBiologicalProcess | negative regulation of vasculature development | 1.36e-04 | 180 | 12 | 3 | GO:1901343 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 2.64e-04 | 42 | 12 | 2 | GO:0006910 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 3.45e-04 | 48 | 12 | 2 | GO:0043277 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 3.89e-04 | 51 | 12 | 2 | GO:0050919 | |
| GeneOntologyBiologicalProcess | phagocytosis | 4.67e-04 | 274 | 12 | 3 | GO:0006909 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 6.63e-04 | 309 | 12 | 3 | GO:1901888 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 7.12e-04 | 69 | 12 | 2 | GO:0006911 | |
| GeneOntologyBiologicalProcess | circulatory system development | 8.67e-04 | 1442 | 12 | 5 | GO:0072359 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 9.09e-04 | 78 | 12 | 2 | GO:0099024 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse assembly | 1.10e-03 | 86 | 12 | 2 | GO:0051965 | |
| GeneOntologyBiologicalProcess | membrane invagination | 1.13e-03 | 87 | 12 | 2 | GO:0010324 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 1.18e-03 | 89 | 12 | 2 | GO:2000379 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.10e-07 | 530 | 12 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 7.34e-07 | 656 | 12 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 7.47e-07 | 658 | 12 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.26e-03 | 93 | 12 | 2 | GO:0031091 | |
| GeneOntologyCellularComponent | basement membrane | 2.15e-03 | 122 | 12 | 2 | GO:0005604 | |
| GeneOntologyCellularComponent | non-motile cilium | 5.43e-03 | 196 | 12 | 2 | GO:0097730 | |
| Domain | TSP_1 | 6.79e-21 | 63 | 12 | 9 | PF00090 | |
| Domain | TSP1_rpt | 9.17e-21 | 65 | 12 | 9 | IPR000884 | |
| Domain | TSP1 | 9.17e-21 | 65 | 12 | 9 | PS50092 | |
| Domain | TSP1 | 9.17e-21 | 65 | 12 | 9 | SM00209 | |
| Domain | VWFC_1 | 1.43e-06 | 36 | 12 | 3 | PS01208 | |
| Domain | VWC | 1.69e-06 | 38 | 12 | 3 | SM00214 | |
| Domain | VWFC_2 | 1.69e-06 | 38 | 12 | 3 | PS50184 | |
| Domain | VWF_dom | 2.29e-06 | 42 | 12 | 3 | IPR001007 | |
| Domain | TSP_3 | 3.78e-06 | 5 | 12 | 2 | PF02412 | |
| Domain | Thrombospondin_3-like_rpt | 3.78e-06 | 5 | 12 | 2 | IPR003367 | |
| Domain | TSP3 | 3.78e-06 | 5 | 12 | 2 | PS51234 | |
| Domain | TSP_CTER | 3.78e-06 | 5 | 12 | 2 | PS51236 | |
| Domain | - | 3.78e-06 | 5 | 12 | 2 | 4.10.1080.10 | |
| Domain | TSP_type-3_rpt | 3.78e-06 | 5 | 12 | 2 | IPR028974 | |
| Domain | Thrombospondin_C | 3.78e-06 | 5 | 12 | 2 | IPR008859 | |
| Domain | TSP_C | 3.78e-06 | 5 | 12 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 3.78e-06 | 5 | 12 | 2 | IPR017897 | |
| Domain | TSPN | 9.50e-05 | 23 | 12 | 2 | SM00210 | |
| Domain | VWC | 1.42e-04 | 28 | 12 | 2 | PF00093 | |
| Domain | I-set | 2.13e-04 | 190 | 12 | 3 | PF07679 | |
| Domain | Ig_I-set | 2.13e-04 | 190 | 12 | 3 | IPR013098 | |
| Domain | GPS | 2.36e-04 | 36 | 12 | 2 | PS50221 | |
| Domain | GPS | 2.49e-04 | 37 | 12 | 2 | IPR000203 | |
| Domain | Ig_sub2 | 3.98e-04 | 235 | 12 | 3 | IPR003598 | |
| Domain | EGF_3 | 3.98e-04 | 235 | 12 | 3 | PS50026 | |
| Domain | IGc2 | 3.98e-04 | 235 | 12 | 3 | SM00408 | |
| Domain | EGF_1 | 5.05e-04 | 255 | 12 | 3 | PS00022 | |
| Domain | EGF_2 | 5.65e-04 | 265 | 12 | 3 | PS01186 | |
| Domain | Laminin_G | 6.13e-04 | 58 | 12 | 2 | IPR001791 | |
| Domain | EGF_CA | 1.34e-03 | 86 | 12 | 2 | PF07645 | |
| Domain | - | 1.63e-03 | 95 | 12 | 2 | 2.60.120.200 | |
| Domain | Ig_sub | 2.15e-03 | 421 | 12 | 3 | IPR003599 | |
| Domain | IG | 2.15e-03 | 421 | 12 | 3 | SM00409 | |
| Domain | EGF_CA | 2.68e-03 | 122 | 12 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.76e-03 | 124 | 12 | 2 | IPR001881 | |
| Domain | IG_LIKE | 3.33e-03 | 491 | 12 | 3 | PS50835 | |
| Domain | Ig-like_dom | 3.56e-03 | 503 | 12 | 3 | IPR007110 | |
| Domain | - | 7.71e-03 | 663 | 12 | 3 | 2.60.40.10 | |
| Domain | ConA-like_dom | 8.36e-03 | 219 | 12 | 2 | IPR013320 | |
| Domain | Ig-like_fold | 9.16e-03 | 706 | 12 | 3 | IPR013783 | |
| Domain | EGF | 9.57e-03 | 235 | 12 | 2 | SM00181 | |
| Domain | EGF-like_dom | 1.07e-02 | 249 | 12 | 2 | IPR000742 | |
| Domain | EGF-like_CS | 1.17e-02 | 261 | 12 | 2 | IPR013032 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.67e-11 | 39 | 11 | 5 | MM15165 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.67e-11 | 39 | 11 | 5 | M27417 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.02e-09 | 68 | 11 | 5 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.12e-08 | 109 | 11 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.23e-08 | 111 | 11 | 5 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.41e-08 | 143 | 11 | 5 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 7.14e-07 | 250 | 11 | 5 | M27554 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 2.88e-04 | 33 | 11 | 2 | M277 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 4.91e-04 | 43 | 11 | 2 | M39565 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.63e-04 | 57 | 11 | 2 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.93e-04 | 58 | 11 | 2 | M2049 | |
| Pathway | WP_P53_SIGNALING | 1.12e-03 | 65 | 11 | 2 | MM15852 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.16e-03 | 66 | 11 | 2 | M18 | |
| Pathway | KEGG_P53_SIGNALING_PATHWAY | 1.23e-03 | 68 | 11 | 2 | M6370 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.86e-03 | 84 | 11 | 2 | M7098 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.95e-03 | 86 | 11 | 2 | M2642 | |
| Pathway | WP_BARDETBIEDL_SYNDROME | 2.04e-03 | 88 | 11 | 2 | M45557 | |
| Pathway | WP_P53_TRANSCRIPTIONAL_GENE_NETWORK | 2.43e-03 | 96 | 11 | 2 | M40062 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 2.43e-03 | 96 | 11 | 2 | M39581 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 2.56e-03 | 1389 | 11 | 5 | MM15307 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 3.35e-03 | 1475 | 11 | 5 | M19806 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.58e-03 | 418 | 11 | 3 | MM15587 | |
| Pathway | KEGG_AXON_GUIDANCE | 4.33e-03 | 129 | 11 | 2 | M5539 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.03e-03 | 532 | 11 | 3 | M27870 | |
| Pathway | WP_CILIOPATHIES | 8.62e-03 | 184 | 11 | 2 | M39880 | |
| Pathway | WP_FOCAL_ADHESION | 8.90e-03 | 187 | 11 | 2 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 1.00e-02 | 199 | 11 | 2 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.00e-02 | 199 | 11 | 2 | M7253 | |
| Pubmed | 1.28e-16 | 75 | 12 | 7 | 20637190 | ||
| Pubmed | 5.86e-09 | 210 | 12 | 5 | 16537572 | ||
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 1.09e-07 | 2 | 12 | 2 | 16181801 | |
| Pubmed | Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. | 1.09e-07 | 2 | 12 | 2 | 15037577 | |
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 38339060 | ||
| Pubmed | Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. | 1.09e-07 | 2 | 12 | 2 | 10027393 | |
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 17620335 | ||
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 33372257 | ||
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 21762961 | ||
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 30928339 | ||
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 1.09e-07 | 2 | 12 | 2 | 23660684 | |
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 9694593 | ||
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 39122122 | ||
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 34425286 | ||
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 12213711 | ||
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 1.09e-07 | 2 | 12 | 2 | 22930728 | |
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 17143334 | ||
| Pubmed | Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. | 1.09e-07 | 2 | 12 | 2 | 33759165 | |
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 1.09e-07 | 2 | 12 | 2 | 8126073 | |
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 33981184 | ||
| Pubmed | Thrombospondin expression in aldosterone-producing adenomas. | 1.09e-07 | 2 | 12 | 2 | 12358136 | |
| Pubmed | Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. | 1.09e-07 | 2 | 12 | 2 | 18594557 | |
| Pubmed | A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. | 1.09e-07 | 2 | 12 | 2 | 1712771 | |
| Pubmed | Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1. | 3.27e-07 | 3 | 12 | 2 | 16598380 | |
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 26241338 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 9373030 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 27513329 | ||
| Pubmed | Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. | 3.27e-07 | 3 | 12 | 2 | 18787106 | |
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 15347840 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 30939949 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 18032585 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 18178577 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 25976449 | ||
| Pubmed | Interactions between CD47 and thrombospondin reduce inflammation. | 3.27e-07 | 3 | 12 | 2 | 17442977 | |
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 19004835 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 3.27e-07 | 3 | 12 | 2 | 8400410 | |
| Pubmed | Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. | 3.27e-07 | 3 | 12 | 2 | 8463250 | |
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 31092423 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 19818485 | ||
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 3.27e-07 | 3 | 12 | 2 | 12482844 | |
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 15864306 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 3.27e-07 | 3 | 12 | 2 | 1459996 | |
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 33069367 | ||
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 3.27e-07 | 3 | 12 | 2 | 26168731 | |
| Pubmed | EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins. | 3.27e-07 | 3 | 12 | 2 | 17638877 | |
| Pubmed | 6.55e-07 | 4 | 12 | 2 | 12909644 | ||
| Pubmed | 6.55e-07 | 4 | 12 | 2 | 19147503 | ||
| Pubmed | 6.55e-07 | 4 | 12 | 2 | 11980922 | ||
| Pubmed | 6.55e-07 | 4 | 12 | 2 | 10900205 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 6.55e-07 | 4 | 12 | 2 | 6338048 | |
| Pubmed | 6.55e-07 | 4 | 12 | 2 | 20847111 | ||
| Pubmed | 6.55e-07 | 4 | 12 | 2 | 18089612 | ||
| Pubmed | 1.09e-06 | 5 | 12 | 2 | 30622267 | ||
| Pubmed | 1.09e-06 | 5 | 12 | 2 | 23806329 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 3.05e-06 | 8 | 12 | 2 | 24460873 | |
| Pubmed | 3.92e-06 | 9 | 12 | 2 | 1371115 | ||
| Pubmed | Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program. | 9.91e-06 | 14 | 12 | 2 | 28729362 | |
| Pubmed | 1.55e-05 | 146 | 12 | 3 | 27068509 | ||
| Pubmed | 4.72e-05 | 30 | 12 | 2 | 22171010 | ||
| Pubmed | 6.45e-05 | 35 | 12 | 2 | 35858542 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 1.43e-04 | 52 | 12 | 2 | 30389913 | |
| Pubmed | 1.43e-04 | 52 | 12 | 2 | 26633812 | ||
| Pubmed | 1.85e-04 | 59 | 12 | 2 | 21421844 | ||
| Pubmed | 2.17e-04 | 64 | 12 | 2 | 22261194 | ||
| Pubmed | 2.64e-04 | 985 | 12 | 4 | 12975309 | ||
| Pubmed | 2.68e-04 | 71 | 12 | 2 | 33541421 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 3.31e-04 | 79 | 12 | 2 | 18757743 | |
| Interaction | DPY19L3 interactions | 3.24e-07 | 24 | 12 | 3 | int:DPY19L3 | |
| Interaction | B3GLCT interactions | 1.14e-06 | 36 | 12 | 3 | int:B3GLCT | |
| Interaction | MMP2 interactions | 1.66e-05 | 87 | 12 | 3 | int:MMP2 | |
| Interaction | THBS2 interactions | 5.53e-05 | 19 | 12 | 2 | int:THBS2 | |
| Interaction | MMP9 interactions | 7.03e-04 | 67 | 12 | 2 | int:MMP9 | |
| Interaction | THBS3 interactions | 8.57e-04 | 74 | 12 | 2 | int:THBS3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q21 | 7.79e-04 | 160 | 12 | 2 | chr3q21 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.13e-03 | 161 | 8 | 2 | 593 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.48e-08 | 191 | 12 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.69e-08 | 196 | 12 | 5 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 8.34e-08 | 270 | 12 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 9.14e-08 | 275 | 12 | 5 | M5884 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 2.35e-06 | 59 | 12 | 3 | M47993 | |
| Coexpression | NABA_MATRISOME | 2.41e-06 | 1008 | 12 | 6 | MM17056 | |
| Coexpression | NABA_MATRISOME | 2.67e-06 | 1026 | 12 | 6 | M5889 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 1.05e-05 | 11 | 12 | 2 | M566 | |
| Coexpression | GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP | 2.90e-05 | 136 | 12 | 3 | M8939 | |
| Coexpression | LIEN_BREAST_CARCINOMA_METAPLASTIC | 1.01e-04 | 33 | 12 | 2 | M11654 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 1.27e-04 | 37 | 12 | 2 | M16643 | |
| Coexpression | BERNARD_PPAPDC1B_TARGETS_DN | 3.24e-04 | 59 | 12 | 2 | M8123 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 3.24e-04 | 59 | 12 | 2 | M47989 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 3.58e-04 | 62 | 12 | 2 | M1576 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 3.81e-04 | 64 | 12 | 2 | MM671 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 4.43e-04 | 69 | 12 | 2 | M10165 | |
| Coexpression | LI_ESTROGENE_LATE_E2_RESPONSE_DN | 5.95e-04 | 80 | 12 | 2 | M48218 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP | 6.41e-04 | 83 | 12 | 2 | M17951 | |
| Coexpression | ZHU_CMV_24_HR_DN | 6.56e-04 | 84 | 12 | 2 | M4065 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS | 7.36e-04 | 89 | 12 | 2 | M40280 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 7.69e-04 | 91 | 12 | 2 | M40180 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | 6.11e-05 | 412 | 12 | 4 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#4_top-relative-expression-ranked_500 | 1.58e-04 | 195 | 12 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.58e-04 | 195 | 12 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.28e-04 | 250 | 12 | 3 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | 3.34e-04 | 1208 | 12 | 5 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.86e-04 | 305 | 12 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#4_top-relative-expression-ranked_200 | 6.53e-04 | 68 | 12 | 2 | gudmap_developingKidney_e13.5_podocyte cells_200_k4 | |
| CoexpressionAtlas | BM Top 100 - lymph nodes | 6.53e-04 | 68 | 12 | 2 | BM Top 100 - lymph nodes | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_500 | 7.52e-04 | 73 | 12 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_1000 | 8.10e-04 | 809 | 12 | 4 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 8.37e-04 | 77 | 12 | 2 | GSM854294_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 9.25e-04 | 81 | 12 | 2 | GSM605865_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#5 | 9.48e-04 | 82 | 12 | 2 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K5 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 9.95e-04 | 84 | 12 | 2 | GSM605862_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#3 | 9.95e-04 | 84 | 12 | 2 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K3 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.04e-03 | 86 | 12 | 2 | GSM777055_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_100 | 1.04e-03 | 86 | 12 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_500_k-means-cluster#4 | 1.04e-03 | 86 | 12 | 2 | ratio_SC_vs_DE_500_K4 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 1.04e-03 | 86 | 12 | 2 | GSM605850_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.07e-03 | 87 | 12 | 2 | GSM777050_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 1.17e-03 | 91 | 12 | 2 | GSM538280_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.27e-03 | 95 | 12 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#2 | 1.41e-03 | 100 | 12 | 2 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2 | 1.49e-03 | 103 | 12 | 2 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 1.55e-03 | 105 | 12 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 1.58e-03 | 967 | 12 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.64e-03 | 978 | 12 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.66e-03 | 437 | 12 | 3 | GSM777046_500 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.07e-08 | 168 | 12 | 4 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-07 | 190 | 12 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.61e-07 | 194 | 12 | 4 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 172 | 12 | 3 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 180 | 12 | 3 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 180 | 12 | 3 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 180 | 12 | 3 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 180 | 12 | 3 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 184 | 12 | 3 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.46e-05 | 185 | 12 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.46e-05 | 185 | 12 | 3 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-05 | 185 | 12 | 3 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.49e-05 | 186 | 12 | 3 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-05 | 186 | 12 | 3 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.51e-05 | 187 | 12 | 3 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-05 | 189 | 12 | 3 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | (2)_Fibroblasts-(22)_Fibro-3|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.59e-05 | 190 | 12 | 3 | 3aed03b87ba2c8d479048c3ceef3ff5e38746c28 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.59e-05 | 190 | 12 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Limb_Muscle|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 190 | 12 | 3 | 06c2b13fa88abbcb8086f13b8d98a156e41e4198 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 190 | 12 | 3 | ad0f5605db6b694445ec9bd5dc8d2d834358c0f9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 190 | 12 | 3 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 190 | 12 | 3 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 191 | 12 | 3 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-05 | 191 | 12 | 3 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 191 | 12 | 3 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.61e-05 | 191 | 12 | 3 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.61e-05 | 191 | 12 | 3 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 192 | 12 | 3 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 12 | 3 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 192 | 12 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 192 | 12 | 3 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 12 | 3 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 12 | 3 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 12 | 3 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 192 | 12 | 3 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 192 | 12 | 3 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-05 | 192 | 12 | 3 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 192 | 12 | 3 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 193 | 12 | 3 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-05 | 193 | 12 | 3 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 193 | 12 | 3 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.69e-05 | 194 | 12 | 3 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.69e-05 | 194 | 12 | 3 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 194 | 12 | 3 | c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 12 | 3 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 195 | 12 | 3 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 12 | 3 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 195 | 12 | 3 | fc43cd295f2cc3f6e9442232e028944f011c82cc | |
| ToppCell | COVID-19-Heart-Low_count_Fib|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-05 | 195 | 12 | 3 | e09590d1f51d5fa57fceb84c9f48f84b23d4d224 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 196 | 12 | 3 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 196 | 12 | 3 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.77e-05 | 197 | 12 | 3 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.77e-05 | 197 | 12 | 3 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 197 | 12 | 3 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-05 | 197 | 12 | 3 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 198 | 12 | 3 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 198 | 12 | 3 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 198 | 12 | 3 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.79e-05 | 198 | 12 | 3 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.82e-05 | 199 | 12 | 3 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 199 | 12 | 3 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.85e-05 | 200 | 12 | 3 | e663995fc44c340d878d66b278b7b5c2ff784301 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.85e-05 | 200 | 12 | 3 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-05 | 200 | 12 | 3 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.85e-05 | 200 | 12 | 3 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 200 | 12 | 3 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-05 | 200 | 12 | 3 | 2cb8a39a12522a9643c6244d5e94cb4559868bb9 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-05 | 200 | 12 | 3 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.85e-05 | 200 | 12 | 3 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.85e-05 | 200 | 12 | 3 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-05 | 200 | 12 | 3 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 200 | 12 | 3 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-05 | 200 | 12 | 3 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.85e-05 | 200 | 12 | 3 | 8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 200 | 12 | 3 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 79 | 12 | 2 | a60fcbb278ba629af922c53faf58e4d96c537b15 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 79 | 12 | 2 | 239d34f40c3a96186231f3aabd41c4988af3f372 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.37e-04 | 103 | 12 | 2 | 39d8cfb899ca88c72ebe021d66cc21ae2eb6a1cc | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.37e-04 | 103 | 12 | 2 | 01a7baaa0c3903bd00e37717856d2c1ac21bf2c8 | |
| ToppCell | -IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 5.20e-04 | 128 | 12 | 2 | dab10774bc0532a1664fd8ac2b54cffab01be55a | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.53e-04 | 132 | 12 | 2 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.53e-04 | 132 | 12 | 2 | 560e836764ed7806fb18282dfebe434d30112a9a | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.70e-04 | 134 | 12 | 2 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.70e-04 | 134 | 12 | 2 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 137 | 12 | 2 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 137 | 12 | 2 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.22e-04 | 140 | 12 | 2 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.67e-04 | 145 | 12 | 2 | 88e463d5396a8fea2b7b1ecf3c9b144e16b35234 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.67e-04 | 145 | 12 | 2 | 911fee7f27694393e348d94470a1a4e890038902 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.85e-04 | 147 | 12 | 2 | c5913cc351577e54536dd239a33e5f7a5cb79672 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.94e-04 | 148 | 12 | 2 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 7.22e-04 | 151 | 12 | 2 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 7.22e-04 | 151 | 12 | 2 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-04 | 152 | 12 | 2 | 962f5bf632da79bd933193d3edd7d89941a85831 | |
| ToppCell | Myeloid-C_(Monocyte)|World / shred on cell class and cell subclass (v4) | 7.32e-04 | 152 | 12 | 2 | 9145dc014ed7f154c158d454dc2b9754396afcca | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.42e-04 | 153 | 12 | 2 | 65641cc82883716dba0fefb749a30174a63f4da5 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 154 | 12 | 2 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 154 | 12 | 2 | 8746663a822d93a8510081c81a8c971b51653067 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 154 | 12 | 2 | 27f76e4b3c055aa382708f1610c685f02d6d6114 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.61e-04 | 155 | 12 | 2 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.83e-04 | 50 | 8 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9 | |
| Drug | chondroitin sulfate | 4.71e-05 | 413 | 12 | 4 | CID000024766 | |
| Drug | DB04780 | 8.56e-05 | 170 | 12 | 3 | CID005459389 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 1.17e-04 | 31 | 12 | 2 | ctd:C577942 | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.31e-04 | 196 | 12 | 3 | 4548_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; HL60; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 2191_UP | |
| Drug | Fosfosal [6064-83-1]; Up 200; 18.4uM; PC3; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 4239_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; HL60; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 2472_UP | |
| Drug | genistein; Up 200; 10uM; PC3; HT_HG-U133A | 1.37e-04 | 199 | 12 | 3 | 4459_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; HL60; HT_HG-U133A | 1.39e-04 | 200 | 12 | 3 | 3130_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.39e-04 | 200 | 12 | 3 | 2973_UP | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 1.39e-04 | 200 | 12 | 3 | 6415_DN | |
| Drug | biphenylene | 1.42e-04 | 34 | 12 | 2 | CID000009214 | |
| Drug | Val-Val | 1.87e-04 | 39 | 12 | 2 | CID000107475 | |
| Drug | Rgd Peptide | 2.34e-04 | 239 | 12 | 3 | CID000104802 | |
| Drug | 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea | 2.83e-04 | 48 | 12 | 2 | ctd:C581572 | |
| Drug | Nor 3 | 3.08e-04 | 50 | 12 | 2 | CID009578441 | |
| Drug | GSK1210151A | 3.33e-04 | 52 | 12 | 2 | ctd:C568713 | |
| Disease | Lumbar disc disease | 1.52e-06 | 5 | 12 | 2 | C0221775 | |
| Disease | INTERVERTEBRAL DISC DISEASE | 1.52e-06 | 5 | 12 | 2 | 603932 | |
| Disease | Intervertebral disc disorder | 1.52e-06 | 5 | 12 | 2 | cv:C0158252 | |
| Disease | Intervertebral disc disorder | 2.27e-06 | 6 | 12 | 2 | C0158252 | |
| Disease | Microangiopathy, Diabetic | 1.81e-05 | 16 | 12 | 2 | C0025945 | |
| Disease | Diabetic Angiopathies | 1.81e-05 | 16 | 12 | 2 | C0011875 | |
| Disease | colorectal cancer (is_marker_for) | 1.79e-03 | 157 | 12 | 2 | DOID:9256 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | 8.27e-03 | 1074 | 12 | 3 | C0006142 | |
| Disease | amyloid-beta measurement | 8.80e-03 | 355 | 12 | 2 | EFO_0005194 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AWDEWSPWSLCSSTC | 411 | O14514 | |
| LSPIWSICWNPSSRW | 176 | Q9HBG6 | |
| IPDTTFTSVPCAWWW | 371 | Q6PIU1 | |
| RSPRWSLWSTWAPCS | 76 | P27918 | |
| WATWGPWTPCSASCH | 196 | P27918 | |
| SWSEWSTWGLCMPPC | 381 | P27918 | |
| PWWSSAVWAICGTAS | 2131 | Q8TDX9 | |
| WTPWTSWSSCSQSCL | 2776 | A2VEC9 | |
| PSIWGLWAPWSTCSA | 2831 | A2VEC9 | |
| TWSPWTPWSQCSASC | 3186 | A2VEC9 | |
| GPWSSWSPCSRSCTD | 3886 | A2VEC9 | |
| WTSWAPWEPCSRSCG | 3951 | A2VEC9 | |
| IWSPWSPWSKCSAAC | 151 | O75339 | |
| GWSPWSEWTSCSTSC | 381 | P07996 | |
| SDTWGPWSQWSPCSR | 26 | O95428 | |
| AWTPWSSWALCSTSC | 666 | Q9P283 | |
| ACPVRGAWSCWTSWS | 906 | Q9P283 | |
| GAWSCWTSWSPCSAS | 911 | Q9P283 | |
| RWSPWSPWSACTVTC | 496 | P35442 | |
| PWSKWSTCGTECTHW | 321 | O95185 |